Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Generation of the antioxidant hydroxytyrosol from tyrosol present in beer and red wine in a randomized clinical trial

  • Soldevila-Domenech, Natalia
  • Boronat, Anna|||0000-0003-0852-3634
  • Mateus Rodriguez, Julian Andres|||0000-0001-8417-3539
  • Díaz-Pellicer, Patricia
  • Matilla, Iris
  • Pérez-Otero, Marta
  • Aldea-Perona, Ana|||0000-0002-3791-8814
  • Torre, Rafael de la|||0000-0002-6765-1866
Beer and wine contains the simple phenol tyrosol (TYR) which is endogenously converted into hydroxytyrosol (HT), one of the strongest dietary antioxidants, by CYP2A6 and CYP2D6 polymorphic enzymes. We investigated in humans the rate of this bioconversion after beer and red wine (RW) intake. In a single blind, randomized, crossover, controlled clinical trial (n = 20 healthy subjects), we evaluated TYR absorption and biotransformation into HT following a single dose of (i) RW, (ii) Indian pale ale beer (IPA), (iii) blonde beer, and (iv) non-alcoholic beer (free). Individuals were genotyped for CYP2A6 and CYP2D6, and a polygenic activity score (PAS) was derived. RW triggered the highest increase in total TYR recovered, followed by IPA, blonde, and free beers. Although the HT content in beer was minimal, an increase in HT production was observed in all beers following TYR in a dose-response manner, confirming TYR to HT biotransformation. Sex differences were identified in the rate of the conversion following RW. PAS scores correlated linearly with the recoveries of HT (HT:TYR ratios) after RW intake. In conclusion, after beer and RWconsumption, TYR is absorbed and endogenously biotransformed into HT. This mechanism could be modulated by sex, genetics, and matrix components.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Data on the endogenous conversion of tyrosol into hydroxytyrosol in humans

  • Boronat, Anna|||0000-0003-0852-3634
  • Mateus Rodriguez, Julian Andres|||0000-0001-8417-3539
  • Soldevila-Domenech, Natalia
  • Guerra, Mercè
  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Varon, Carlota
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Barbosa, Francina
  • Morales, Juan Carlos|||0000-0003-2400-405X
  • Gaedigk, Andreas
  • Langohr, Klaus|||0000-0001-7075-9192
  • Covas Planells, Maria Isabel
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Tyndale, Rachel F.
  • Torre, Rafael de la|||0000-0002-6765-1866
Here we present new and original data on the endogenous conversion of tyrosol (Tyr) into hydroxytyrosol (OHTyr) in humans and its effects on the cardiovascular system. A randomized, crossover, controlled clinical trial was performed with individuals at cardiovascular risk (n = 33). They received white wine (WW) (females 1, males 2 standard drinks/day), WW plus Tyr capsules (WW + Tyr) (25mg Tyr capsule, one per WW drink), and water (control) ad libitum. Intervention periods were of 4 weeks preceded by three-week wash-out periods. We assessed the conversion of Tyr to OHTyr, its interaction with a polygenic activity score (PAS) from CYP2A6 and CYP2D6 genotypes, and the effects on cardiovascular risk markers. For further details and experimental findings please refer to the article "Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial" [].